×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating ...
Yahoo Finance
CAMBRIDGE, Mass., May 10, 2024--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) ("Merrimack" or the "Company") announced that the...
4 days ago
Merrimack Pharma Plans to Delist, Pending Holder Approval of Liquidation Plan
MarketWatch
By Stephen Nakrosis Merrimack Pharmaceuticals on Tuesday said it filed with the Nasdaq regarding the company's plan to delist its securities...
2 weeks ago
Merrimack Pharmaceuticals stockholders approve plan of dissolution (NASDAQ:MACK)
Seeking Alpha
Merrimack Pharmaceuticals (MACK) stockholders approve dissolution plan; liquidating cash dividend of $15.10/share declared.
4 days ago
FDA Approves New First-Line Med for Pancreatic Cancer as Drug’s Initial Developer Dissolves
MedCity News
Pancreatic cancer continues to be one of the most difficult-to-treat cancers. An Ipsen drug is now approved as a first-line therapy,...
3 months ago
Merrimack Reports Full Year 2023 Financial Results
Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced its full...
2 months ago
Merrimack to dissolve after FDA nod prompts $225 million payment
Investing.com
CAMBRIDGE, Mass. - Merrimack Pharmaceuticals Inc. (NASDAQ:MACK) has announced that it will receive a milestone payment of $225 million from...
3 months ago
With FDA nod for Onivyde combo, Ipsen ends 10-year drought in newly diagnosed pancreatic cancer
Fierce Pharma
It's the approval Ipsen has been waiting for since buying up Onivyde in 2017. The FDA has approved Onivyde as part of a multidrug...
3 months ago
We're Not Worried About Merrimack Pharmaceuticals' (NASDAQ:MACK) Cash Burn
Simply Wall Street
Merrimack Pharmaceuticals didn't record any revenue over the last year, indicating that it's an early stage company still developing its...
3 months ago
Merrimack Pharmaceuticals Weighs Dissolution Post FDA Approval - TipRanks.com
Tipranks
Merrimack Pharmaceuticals Inc. (MACK) has released an update. Merrimack Pharmaceuticals, Inc. has announced FDA approval of Onivyde as a...
3 months ago
Merrimack stock spikes as FDA expands Onivyde label
Seeking Alpha
Merrimack Pharmaceuticals (MACK) stock rises as U.S. FDA approves expansion of pancreatic cancer therapy Onivyde. Read more here.
3 months ago